Law360, New York (September 08, 2011, 6:33 PM ET) -- A Pennsylvania federal judge on Thursday approved the dismissal of health insurer AvMed Inc.'s antitrust claims from consolidated class action litigation against Cephalon Inc. and generics makers over an alleged conspiracy to keep narcolepsy drug Provigil off the market.
AvMed's claims were consolidated with class actions filed over the alleged conspiracy by drug plans, wholesalers and Apotex Inc., who say they were left out of Cephalon's alleged scheme of payoffs to other generic-drug makers. This marks the first dismissal in the case.
The suits claim that...
AvMed Exits Class Suit Alleging Provigil Conspiracy
To view the full article, take a free trial now.
